期刊文献+

卡维地洛抑制大鼠心脏成纤维细胞增殖及胶原合成的实验研究

Effect of Carvedilol on Proliferation and Collagen Synthesis of Cultured Cardiac Fibroblasts from Rats
下载PDF
导出
摘要 【目的】探讨卡维地洛对的实验性大鼠(Wistar)心脏成纤维细胞(CFs)增殖及胶原合成的影响。【方法】以12周龄Wistar健康大鼠为研究对象。采用胰酶消化法培养CFs,采用改良的MTT比色法观察CFs的增殖状况,采用3H-胸腺嘧啶核苷(3H-TdR)掺入法测定CFs的DNA合成功能,3H-脯氨酸(3H-Proline)掺入法测定胶原合成。【结果]CFsMTT吸光值随卡维地洛浓度增加和作用时间延长而减低,并呈浓度和时间依赖性;0.01~10.00μmol/L卡维地洛分别干预72h时,Wistar大鼠CFs 3H-TdR及3H-Proline掺入率均较空白对照组明显减低(分别P〈0.05,P〈0.01)。随着卡维地洛干预浓度的增加,其抑制作用逐渐增强,呈浓度依赖性。【结论】卡维地洛可显著抑制CFs的DNA合成及细胞增殖,并进一步抑制胶原沉积及逆转左室肥厚。 [Objective] To observe the effect of carvedilol on proliferation and collagen synthesis in cardiac fibroblast (CFs) derived from Wistar rats. [Methods]Twelve-week old Wistar rats were used in this study. The CFs were isolated and cultured with the method of digestion method. DNA synthesis was measured by 3 H-TdR incorporation, and the cell number was determined by modified MTT array, and the collagen synthe- sis was measured by 3H-proline incorporation, [Results] MTT optical density(OD) value of CFs was decreased by carvedilol in a concentration-dependent and time-dependent manner. After 72-hour culture, with the increase of concentration of carvedilol on CFs, the 3 H-TdR and 3 H-proline incorporation from wistar rats were significantly decreased, compared with control group, ( P〈d0.05, P d0.01 ,respectively), which showed con- centration-dependent effects. [Conclusion]Carvedilol can inhibit significantly DNA synthesis and proliferation, and then inhibit collagen synthesis and attenuate left ventricular hypertrophy of hypertension.
出处 《医学临床研究》 CAS 2009年第1期26-29,共4页 Journal of Clinical Research
关键词 成纤维细胞/药物作用 细胞分裂/药物作用 胶原/生物合成 卡唑类/药理学 大鼠 fibroblasts/DE celldivision/DE collagen/BI carbazoles/PD rats
  • 相关文献

参考文献9

  • 1高天,方宁远,龚伟琦,江立生,傅爱芬,陆惠华.氯沙坦对SHR心肌及心肌血管周围胶原影响的实验研究[J].医学临床研究,2004,21(6):613-615. 被引量:2
  • 2Udelson JE. Ventricular remodeling in heart failure and the effect of β-blockade[J]. Am J Cardial , 2004,93 (9A): 43B- 48B.
  • 3Agabiti-Rosei E, Muiesan ML. Left ventricular hypertrophy and heart failure in women[J]. J Hypertens , 2002,20(suppl 2) : S34-S38.
  • 4Krzesinski JM, Rorive G, Van Gauwenberge H. Hyperten sion and ventricular hypertrophy [J]. Acta Cardiologica , 1996,51(2):143-154.
  • 5Greenbery BH, Mehra M, Teerink JR, et al. Comparison of the effects of carvedilol CR and carvedilol IR on left ventricu lar ejection fraction in patients with heart failure[J]. Am J Cardiol ,2006,29(7A) :53-59.
  • 6Zhao Q,Wu TG,Jiang ZF, et al. Effect of betar blockers on beta(3)-adrenoceptor expression in chronic heart failure[J]. Cardiovasc Drugs Ther ,2007,21(2) :85-90.
  • 7Fujio H, Nakamura K,Matsubara H, et al . Carvedilol inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension [J]. J Cardiovasc Pharmacol ,2006, 47 (2):250-255.
  • 8Brehm BR, Bertsch D, Fallois JV, et al. Beta-blockers of the third generation inbibt endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells[J]. J Cardiovasc Pharmacol , 2000,36 (Ssuppll) :s401-403.
  • 9陈安玲,徐琳.辛伐他汀对乳鼠心脏成纤维细胞DNA合成的影响[J].医学临床研究,2005,22(7):886-888. 被引量:1

二级参考文献23

  • 1Conrad CH, Brooks WW, Hayes JA, et al . Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat [J]. Circulation , 1995, 91(1) :161-168.
  • 2Chapman D, Weber KT, Eghabali M, et al . Regulation of fibrillar collagen type Ⅰ , Ⅲ and basement membrane type Ⅳ collagen gene expression in pressure overloaded rat myocardium[J]. Circ Res , 1990,67:784-789.
  • 3Negre-aminou P, Vliet AK, Erck M, et al . Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors: comparison with other human cell types[J]. Biochem Biophys Acta , 1997, 1345: 259-268.
  • 4Ortiz MB, Coin M, Gomez MB, et at . Mevalonate dependency of the early cell cycle mitogenic response to epidermal growth factor and prostaglandin F2α in Swiss mouse 3T3 cells[J]. J Cell Physiol , 1995,162:139-146.
  • 5Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and rennin-angiotensin-aldosterone system[J]. Circulation , 1991,83: 1849-1865.
  • 6Booz GW, Baker KM. Molecular signaling mechanisms controlling growth and function of cardiac fibroblasts [J].Cardiovas Res , 1995,30: 537-543.
  • 7Laufs U. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing Rho GTPase-induced down-regulation of P27 (kipl)[J]. J Biol Chem , 1999,274:21926-21931.
  • 8MB. Vascular effects of HMG-CoA reductase inhibitor[J].Atherosclerosis , 1998,137:101-109.
  • 9Corsini A, Pazzucconi F, Arnaboldi L, et al. Direct of Effects of Statins on the Vascular Wall [J]. J Cardiovasc Pharmacol , 1998,31:773-778.
  • 10Vrtovsnik F. Lovastatin inhibition of renal epithelial tubular cell proliferation involves a P21ras activated AP-1-dependent pathway[J]. Kidney Int , 1997,52:1016-1027.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部